Centessa Pharmaceuticals (CNTA) Other Non-Current Liabilities (2021 - 2026)
Centessa Pharmaceuticals (CNTA) reported Other Non-Current Liabilities of $29000.0 for Q1 2026, little changed year-over-year from $29000.0 in Q1 2025, and little changed quarter-over-quarter from $29000.0 in Q4 2025.
Centessa Pharmaceuticals (CNTA) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 6 years of Other Non-Current Liabilities data on file, last reported at $29000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $29000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $29000.0 (changed 0.0% YoY), and the FY2025 annual result was $29000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities was little changed at $29000.0 in Q1 2026 per CNTA's latest filing, from $29000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $43000.0 in Q1 2022 and troughed at $29000.0 in Q4 2023.
- A 5-year average of $31333.3 and a median of $29000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities plunged 99.87% in 2022, then changed 0.0% in 2024.
- A 5-year view of Other Non-Current Liabilities shows it stood at $43000.0 in 2022, then slumped by 32.56% to $29000.0 in 2023, then changed by 0.0% to $29000.0 in 2024, then changed by 0.0% to $29000.0 in 2025, then changed by 0.0% to $29000.0 in 2026.
- Business Quant data shows CNTA's Other Non-Current Liabilities at $29000.0 in Q1 2026, $29000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Centessa Pharmaceuticals | 6.10 Bn | 6.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | 29,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 29,000.00 |
| Dec 31, 2023 | 29,000.00 |
| Jun 30, 2022 | 43,000.00 |
| Mar 31, 2022 | 43,000.00 |
| Dec 31, 2021 | 37.70 Mn |
| Sep 30, 2021 | 33.93 Mn |
| Jun 30, 2021 | 33.93 Mn |